Related references
Note: Only part of the references are listed.Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment
Rachael Guenter et al.
SURGERY (2020)
Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase Inhibitors
Rachael E. Guenter et al.
CANCERS (2019)
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
Tobias Hofving et al.
ENDOCRINE-RELATED CANCER (2018)
PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma
Tibor Vag et al.
EJNMMI RESEARCH (2018)
Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells
Julia Wanek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II
Lichun Sun et al.
JOURNAL OF DRUG TARGETING (2016)
Upregulation of Key Molecules for Targeted Imaging and Therapy
Vincent F. Taelman et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience
Constantin Lapa et al.
ONCOTARGET (2016)
Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells
Marije J. Veenstra et al.
Oncotarget (2016)
Repeatability of Gallium-68 DOTATOC Positron Emission Tomographic Imaging in Neuroendocrine Tumors
Yusuf Menda et al.
PANCREAS (2013)
Somatostatin Receptor Subtype 2A Immunohistochemistry Using a New Monoclonal Antibody Selects Tumors Suitable for In Vivo Somatostatin Receptor Targeting
Meike Koerner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems
Swati S. More et al.
CLINICAL CANCER RESEARCH (2011)
Increased uptake of [123I]meta-iodobenzylguanidine, [18F]fluorodopamine, and [3H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors
Lucia Martiniova et al.
ENDOCRINE-RELATED CANCER (2011)
Standard Imaging Techniques for Neuroendocrine Tumors
David L. Bushnell et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Dik J. Kwekkeboom et al.
ENDOCRINE-RELATED CANCER (2010)
Phase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors
Yusuf Menda et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Metastatic carcinoid tumors: A clinical review
JM Zuetenhorst et al.
ONCOLOGIST (2005)
Share Paper
